{"analyses":[{"ciPctValue":"95","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.041","statisticalMethod":"Wilcoxon Rank Sum Test"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"20"}],"units":"Participants"}],"description":"To compare the efficacy of aprepitant plus standard therapy to placebo plus standard therapy in control of nausea and vomiting during conditioning therapy for autologous or allogeneic hematopoietic stem cell transplantation (HSCT) as defined by the number of retch/emesis free days during the study period","groups":[{"description":"Loading dose of 125 mg capsule once a day for one day, then maintenance dose of 80 mg capsule daily through Day +4 of Bone Marrow Transplant","id":"OG000","title":"Aprepitant"},{"description":"Loading dose of 125 mg capsule once a day for one day, then maintenance dose of 80 mg capsule daily through Day +4 of Bone Marrow Transplant","id":"OG001","title":"Placebo (Sugar Pill)"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Up to three weeks","title":"Number of Emesis Free Participants During the Study Period.","type":"PRIMARY","unitOfMeasure":"Participants"}